Venture Visionary Partners LLC Bristol Myers Squibb CO Transaction History

Venture Visionary Partners LLC

  • $2.25 Billion
  • Q3 2024

A detailed history of Venture Visionary Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Venture Visionary Partners LLC holds 107,367 shares of BMY stock, worth $6.1 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
107,367
Previous 97,136 10.53%
Holding current value
$6.1 Million
Previous $4.03 Million 37.73%
% of portfolio
0.25%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$39.66 - $51.75 $405,761 - $529,454
10,231 Added 10.53%
107,367 $5.56 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $216,947 - $285,616
5,390 Added 5.87%
97,136 $4.03 Million
Q1 2024

May 13, 2024
BUY
$47.98 - $54.4 $179,253 - $203,238
3,736 Added 4.24%
91,746 $4.98 Million
Q4 2023

Feb 15, 2024
BUY
$48.48 - $57.85 $32,336 - $38,585
667 Added 0.76%
88,010 $4.52 Million
Q4 2023

Jan 24, 2024
BUY
$48.48 - $57.85 $888,880 - $1.06 Million
18,335 Added 26.57%
87,343 $4.48 Million
Q3 2023

Oct 13, 2023
BUY
$57.89 - $64.73 $5,094 - $5,696
88 Added 0.13%
69,008 $4.01 Million
Q2 2023

Jul 14, 2023
BUY
$63.71 - $70.74 $636,080 - $706,268
9,984 Added 16.94%
68,920 $4.41 Million
Q1 2023

Apr 13, 2023
BUY
$65.71 - $74.53 $76,814 - $87,125
1,169 Added 2.02%
58,936 $4.08 Million
Q4 2022

Feb 09, 2023
BUY
$68.48 - $81.09 $55,537 - $65,763
811 Added 1.42%
57,767 $4.16 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $451 - $266,788
-3,472 Reduced 5.75%
56,956 $4.05 Million
Q2 2022

Jul 26, 2022
BUY
$72.62 - $79.98 $18,009 - $19,835
248 Added 0.41%
60,428 $4.65 Million
Q1 2022

May 03, 2022
SELL
$61.48 - $73.72 $1.32 Million - $1.59 Million
-21,535 Reduced 26.35%
60,180 $4.39 Million
Q4 2021

Feb 08, 2022
SELL
$53.63 - $62.52 $112,193 - $130,791
-2,092 Reduced 2.5%
81,715 $5.09 Million
Q3 2021

Oct 20, 2021
BUY
$59.17 - $69.31 $140,469 - $164,541
2,374 Added 2.92%
83,807 $4.96 Million
Q2 2021

Aug 05, 2021
SELL
$61.91 - $67.42 $66,986 - $72,948
-1,082 Reduced 1.31%
81,433 $5.44 Million
Q1 2021

Apr 27, 2021
BUY
$59.34 - $66.74 $2.3 Million - $2.58 Million
38,686 Added 88.27%
82,515 $5.21 Million
Q4 2020

Jan 27, 2021
BUY
$57.74 - $65.43 $2.26 Million - $2.56 Million
39,093 Added 825.44%
43,829 $2.72 Million
Q3 2020

Oct 22, 2020
BUY
$57.43 - $63.64 $21,134 - $23,419
368 Added 8.42%
4,736 $285,000
Q2 2020

Aug 11, 2020
BUY
$54.82 - $64.09 $493 - $576
9 Added 0.21%
4,368 $256,000
Q1 2020

May 07, 2020
BUY
$46.4 - $67.43 $11,832 - $17,194
255 Added 6.21%
4,359 $242,000
Q4 2019

Feb 06, 2020
BUY
$49.21 - $64.19 $201,957 - $263,435
4,104 New
4,104 $263,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email